Table 5. [Recommended Surveillance for Individuals with McLeod Neuroacanthocytosis Syndrome]. - GeneReviews®

System/Concern	Evaluation	Frequency
Cardiac	W/cardiac involvement	Per treating specialist	Per treating specialist
W/o known cardiac involvement	Cardiac exams (at least Holter EKG, echocardiography & cardiac biomarkers)	Every 2 yrs When findings are abnormal, more frequently depending on cardiologist's eval
Seizures	EEG	Whenever new-onset seizures are suspected
Muscle (rhabdomyolysis)	Serum CK concentration	Regularly, esp when under neuroleptic treatment
Family support & resources	Eval of social, psychological, & financial situation	At each visit

From: McLeod Neuroacanthocytosis Syndrome

GeneReviews^® [Internet].

Adam MP, Feldman J, Mirzaa GM, et al., editors.

Seattle (WA): University of Washington, Seattle; 1993-2024.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.